Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
about
Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexA novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccinationIdentification of class I HLA T cell control epitopes for West Nile virusProperties and applications of single-chain major histocompatibility complex class I molecules.Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection.T cell epitope mapping of the e-protein of West Nile virus in BALB/c mice.Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infectionDNA vaccines encoding the envelope protein of West Nile virus lineages 1 or 2 administered intramuscularly, via electroporation and with recombinant virus protein induce partial protection in large falcons (Falco spp.).The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous systemExpanding the targets available to therapeutic antibodies via novel disease-specific markers.Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination.Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia InfectionHuman Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyCancer genome sequencing and its implications for personalized cancer vaccines.Basic and translational applications of engineered MHC class I proteins.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.Potential targets for pancreatic cancer immunotherapeutics.West Nile virus: the complex biology of an emerging pathogen.TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.CD8 and CD4 T cells in west nile virus immunity and pathogenesis.Quantitating MHC class I ligand production and presentation using TCR-like antibodies.Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection.Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
P2860
Q24737461-090CC38C-5F19-480D-BBBB-BFAB550742A9Q33934227-7F4FA71A-70C4-4F8A-BBC3-821870A30F68Q34764414-B66590A4-0D20-4063-B875-25879C0550C3Q34770618-251380D6-5CF9-4854-B760-EF319B412B3AQ35075017-DA68708D-5F74-44C2-9C03-CC1C633EF5BAQ35123912-80EA0E01-4D20-4D4B-AFB8-76D2DFF27184Q35519408-46822DDB-DA43-41A3-BE49-F201D42F7E5EQ35785988-7966113A-C261-4C30-9EDE-A51CCCF71E2CQ35961637-5261B1F6-48DD-4C9F-8F6B-AA2876530122Q36089982-652F0EF9-3EFF-440A-A024-D79CD0DA45ECQ36119688-460D49CD-24E6-4466-94EB-DBA325CE1F82Q36140382-31B8FE39-72F0-4D94-B72B-01F09EF23210Q36513486-C3EE3AF0-ED75-4756-B317-B045B0D477E5Q36563742-3237E8F4-0914-40B9-A8EF-D9A1EB3BCA0DQ36607383-CDFA3789-9501-4B6E-8576-77619C3EF226Q36921315-D0B3DBDD-E73F-44CA-BE79-96047A297D54Q37123147-2A00EFDE-73AB-4DA1-B274-955E7074E975Q37148184-D11E6517-6E1C-4560-BE05-F7E23778854AQ37787436-338747AD-D1D3-498B-AF69-69E92BDF27ABQ37842337-DCDB502B-2B2C-4728-8A95-F13F7D5D31CCQ37861220-B33764B2-768A-4C52-B4C4-B097F7D2B612Q37876095-E1ECA8EF-3385-4577-8B1D-E336B6F0F966Q37952806-CD1A586B-7503-4AC5-A313-1302ADB40F89Q38155043-5752BF0A-AA0E-46C5-9E5E-1E23C05D85A6Q39208708-FA8C5E6A-D17C-482C-B683-646D547E97ABQ40898202-9C76A150-56A1-49C6-AFAA-4C47A56F5A66Q41135035-3CE3243C-D801-4F0C-9A9E-8586BEC1A7A8Q41916556-3D0249D9-761E-43D1-A0D8-18845BA36BBC
P2860
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@ast
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@en
type
label
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@ast
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@en
prefLabel
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@ast
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@en
P2093
P2860
P356
P1476
Single-chain HLA-A2 MHC trimer ...... hal West Nile virus infection.
@en
P2093
Curtis P McMurtrey
Jon A Weidanz
Sojung Kim
Ted H Hansen
William E Gillanders
William H Hildebrand
P2860
P304
P356
10.4049/JIMMUNOL.0903955
P407
P577
2010-03-08T00:00:00Z